Welcome to the TNL
Our primary mission is to restore lost function after brain injury or disease using electronic devices that interface directly with the brain. Brain-machine interface (BMI) technology can modulate neural circuits, strengthen weakened pathways, and provide non-native conduits through which paralyzed individuals can interact with the world. We strive to advance the clinical viability of this technology and, along the way, to provide new insights about brain physiology. Jointly led by Tim Lucas, a neurosurgeon, and Drew Richardson, a neuroengineer, the TNL has rapid translational capabilities with projects spanning basic science, pre-clinical testing, and clinical trials.
- A new, state-of-the-art epilepsy unit is available for our human studies Tuesday, February 16, 2021
- Our neuroprosthetic tactile sensor work won a Best Paper Award at RFIC Tuesday, August 4, 2020
- Awarded a NIH grant to study a dynamical systems theory of perception Monday, June 15, 2020